{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 3162,
  "pageSize": 60,
  "pageCount": 5333,
  "rows": [
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "geographic_map",
      "function": "establish_context",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/11",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-11",
      "loopMatches": [
        {
          "to": 13,
          "from": 10,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f032299f-6317-41c4-872a-1946f1b13352",
          "evidence": "The loop is opened by highlighting the growing issue of cannabis-associated ED visits (slide 10) and closed by introducing ANEB-001 as a potential solution (slide 13).",
          "position": 0,
          "objective": "What is the cost of not addressing Acute Cannabinoid Intoxication?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 9,
          "beatId": "f4e9eda8-429a-463d-bdb6-de02232c8051",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 9-12 discuss the problem of Acute Cannabinoid Intoxication, its prevalence, and the challenges it poses.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 12,
          "from": 10,
          "beatId": "0ea96b08-c9b7-46c7-bfb5-07b53e86d15d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "Slides 10-12 agitate the problem by providing data on the growth of cannabis-associated ED visits and the deceiving potency of edibles.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "problem_statement",
      "function": "diagnose_problem",
      "notes": "The slide uses a circular infographic layout to connect a visual of cannabis products to three distinct risk categories.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/12",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-12",
      "loopMatches": [
        {
          "to": 13,
          "from": 10,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f032299f-6317-41c4-872a-1946f1b13352",
          "evidence": "The loop is opened by highlighting the growing issue of cannabis-associated ED visits (slide 10) and closed by introducing ANEB-001 as a potential solution (slide 13).",
          "position": 0,
          "objective": "What is the cost of not addressing Acute Cannabinoid Intoxication?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 12,
          "from": 9,
          "beatId": "f4e9eda8-429a-463d-bdb6-de02232c8051",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Problem (Identify pain)",
          "beatSlug": "problem-agitate-solution-problem-identify-pain",
          "evidence": "Slides 9-12 discuss the problem of Acute Cannabinoid Intoxication, its prevalence, and the challenges it poses.",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        },
        {
          "to": 12,
          "from": 10,
          "beatId": "0ea96b08-c9b7-46c7-bfb5-07b53e86d15d",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Agitate (Make it worse)",
          "beatSlug": "problem-agitate-solution-agitate-make-it-worse",
          "evidence": "Slides 10-12 agitate the problem by providing data on the growth of cannabis-associated ED visits and the deceiving potency of edibles.",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Development",
          "parentBeatSlug": "development"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "propose_solution",
      "function": "present_solution",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/13",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-13",
      "loopMatches": [
        {
          "to": 13,
          "from": 10,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "f032299f-6317-41c4-872a-1946f1b13352",
          "evidence": "The loop is opened by highlighting the growing issue of cannabis-associated ED visits (slide 10) and closed by introducing ANEB-001 as a potential solution (slide 13).",
          "position": 0,
          "objective": "What is the cost of not addressing Acute Cannabinoid Intoxication?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "before_after",
      "function": "present_solution",
      "notes": "Uses a before-after visual comparison to explain the mechanism of action.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/14",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to illustrate the progression from Part A to Part B.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/15",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "roadmap",
      "function": "state_next_steps",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/16",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a linear process flow with icons to represent key development milestones.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/17",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 18,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/18",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-18",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 19,
      "slideType": "transition",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/19",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-19",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 20,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/20",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-20",
      "loopMatches": [
        {
          "to": 24,
          "from": 20,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "1f2417df-59a7-4dba-a852-ef433df43395",
          "evidence": "The loop is opened by providing an update on ANEB-001's clinical development (slide 20) and closed by presenting positive results from the clinical trial (slides 24).",
          "position": 1,
          "objective": "How does ANEB-001 perform in clinical trials?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 21,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/21",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-21",
      "loopMatches": [
        {
          "to": 24,
          "from": 20,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "1f2417df-59a7-4dba-a852-ef433df43395",
          "evidence": "The loop is opened by providing an update on ANEB-001's clinical development (slide 20) and closed by presenting positive results from the clinical trial (slides 24).",
          "position": 1,
          "objective": "How does ANEB-001 perform in clinical trials?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 22,
      "slideType": "other",
      "function": "establish_context",
      "notes": "Clinical trial summary slide.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/22",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-22",
      "loopMatches": [
        {
          "to": 24,
          "from": 20,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "1f2417df-59a7-4dba-a852-ef433df43395",
          "evidence": "The loop is opened by providing an update on ANEB-001's clinical development (slide 20) and closed by presenting positive results from the clinical trial (slides 24).",
          "position": 1,
          "objective": "How does ANEB-001 perform in clinical trials?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 23,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/23",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-23",
      "loopMatches": [
        {
          "to": 24,
          "from": 20,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "1f2417df-59a7-4dba-a852-ef433df43395",
          "evidence": "The loop is opened by providing an update on ANEB-001's clinical development (slide 20) and closed by presenting positive results from the clinical trial (slides 24).",
          "position": 1,
          "objective": "How does ANEB-001 perform in clinical trials?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 24,
      "slideType": "before_after",
      "function": "analyze_data",
      "notes": "The chart displays a time-course study of VAS (Visual Analog Scale) scores for 'feeling high' across three cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/24",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-24",
      "loopMatches": [
        {
          "to": 24,
          "from": 20,
          "name": "Jobs To Be Done",
          "slug": "53-jobs-to-be-done",
          "bestFor": "Product innovation, market entry, competitive positioning",
          "matchId": "1f2417df-59a7-4dba-a852-ef433df43395",
          "evidence": "The loop is opened by providing an update on ANEB-001's clinical development (slide 20) and closed by presenting positive results from the clinical trial (slides 24).",
          "position": 1,
          "objective": "How does ANEB-001 perform in clinical trials?",
          "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
          "confidence": 0.7,
          "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 25,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "VAS = Visual Analog Scale. Data shows a significant reduction in subjective 'high' feeling with ANEB-001 compared to placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/25",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-25",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The data shows a significant reduction in the proportion of subjects feeling high when treated with ANEB-001 compared to placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/26",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "before_after",
      "function": "analyze_data",
      "notes": "The chart shows a reduction in body sway for both 50mg and 100mg doses of ANEB-001 compared to placebo.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/27",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "other",
      "function": "analyze_data",
      "notes": "The chart displays mean values with 95% confidence intervals. Statistical significance is indicated by asterisks.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/28",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a cascading process diagram to illustrate the iterative nature of the study cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/29",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a cascading process flow to show how multiple data streams feed into a central analysis and final model.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/30",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "other",
      "function": "present_framework",
      "notes": "The slide uses a flow diagram to illustrate the randomized, double-blind, placebo-controlled study structure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/31",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide uses a process flow diagram to illustrate the clinical trial methodology.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/32",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "key_messages",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/33",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a smaller inset chart comparing current data to prior 50/100 mg dose data.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/34",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a smaller inset chart showing prior 50/100 mg data for comparison.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/35",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a primary chart and a smaller inset chart for comparison.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/36",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "Includes a primary chart and a smaller inset chart showing similar data for different dosage levels.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/37",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The chart displays mean values with SEM error bars for various THC doses and ANEB-001 treatment groups.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/38",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide displays PK data on both linear and log scales to demonstrate dose-related exposure and half-life characteristics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/39",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The slide compares six different treatment arms across two scales to demonstrate dose-related exposure.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/40",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/41",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "other",
      "function": "present_framework",
      "notes": "Clinical trial update slide.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/42",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "appendix_methodology",
      "function": "present_framework",
      "notes": "The slide outlines the methodology for a clinical study, including target sample size (120) and duration (12 months).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/43",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "other",
      "function": "present_framework",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/44",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/45",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "other",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/46",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/47",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/48",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 48,
          "from": 13,
          "beatId": "684e64de-8d19-434b-83aa-4bfe1e4eb804",
          "arcName": "Problem-Agitate-Solution",
          "arcSlug": "problem-agitate-solution",
          "beatName": "Solution (Provide relief)",
          "beatSlug": "problem-agitate-solution-solution-provide-relief",
          "evidence": "Slides 13-48 present ANEB-001 as a solution, detailing its pharmacology, clinical trial results, and development plan.",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": "Resolution",
          "parentBeatSlug": "resolution"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/49",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "closing_ask",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/50",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a linear process flow with icons representing each stage.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/51",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "key_takeaways",
      "function": "summarize",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/52",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-7953-75ff-b7a7-421adee0c76c",
      "docSlug": "f2ba5faea717d1fc1a89b119873b0327",
      "documentTitle": "Anebulo Pharmaceuticals | Investor Day Presentation Deck | 53 slides",
      "authorId": "anebulo-pharmaceuticals",
      "authorName": "Anebulo Pharmaceuticals",
      "documentKindSlug": "conference-presentation",
      "documentKindLabel": "Conference presentation",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "appendix",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-7953-75ff-b7a7-421adee0c76c/53",
      "deckHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c",
      "deckAnchorHref": "/decks/019de073-7953-75ff-b7a7-421adee0c76c#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 1,
      "slideType": "cover",
      "function": "front_matter",
      "notes": "Includes company logo, date, and ticker symbol.",
      "imagePath": "https://imgproxy.kitesheet.com/WjTEXvOgV8P9NucJxG_AcNlfJHEZ7CuAbT2CeW6cbfY/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYmJkNzIxYmQyNDY2Mzc3MDZkYWIwOWQ1YzRmMzE2NS9wMDAxLmpwZw",
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/1",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-1",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": "https://imgproxy.kitesheet.com/RtHxxoioFNiELbApIu3D9syZRkERvFQ5EYvSeEDpxug/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYmJkNzIxYmQyNDY2Mzc3MDZkYWIwOWQ1YzRmMzE2NS9wMDAxLnBuZw",
      "thumbSrc": "https://imgproxy.kitesheet.com/mlfL8pd-yCzFAby3YNS_Z1Kp7hY08nNcycLdv3qXt4g/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYmJkNzIxYmQyNDY2Mzc3MDZkYWIwOWQ1YzRmMzE2NS9wMDAxLmpwZw",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/No4PQ-ZZtr8r9BBVOP1vEWNYgjM8R_61nF3Bl3qXatU/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy8zYmJkNzIxYmQyNDY2Mzc3MDZkYWIwOWQ1YzRmMzE2NS9wMDAxLnBuZw"
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 2,
      "slideType": "disclaimer",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/2",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-2",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 3,
      "slideType": "executive_summary",
      "function": "summarize",
      "notes": "The slide uses a three-column structure to summarize the company's value proposition.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/3",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-3",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "da168929-7490-4525-afaf-0185eb5bfe52",
          "evidence": "The problem section implies that the cost of inaction is high",
          "position": 0,
          "objective": "What is the cost of not investing in innovative cancer treatments?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "78d6a8df-6efc-40db-93fc-ce9f8bc4283c",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 3-5 present an overview of the current state of cancer treatment and the need for innovative solutions",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 4,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a Gantt-style chart to show clinical trial progress for multiple assets.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/4",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-4",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "da168929-7490-4525-afaf-0185eb5bfe52",
          "evidence": "The problem section implies that the cost of inaction is high",
          "position": 0,
          "objective": "What is the cost of not investing in innovative cancer treatments?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "78d6a8df-6efc-40db-93fc-ce9f8bc4283c",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 3-5 present an overview of the current state of cancer treatment and the need for innovative solutions",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 5,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a Gantt-style timeline to track clinical trial progress (P2 data, enrollment, FPI) against calendar years.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/5",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-5",
      "loopMatches": [
        {
          "to": 5,
          "from": 3,
          "name": "Cost Of Inaction",
          "slug": "27-cost-of-inaction",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "matchId": "da168929-7490-4525-afaf-0185eb5bfe52",
          "evidence": "The problem section implies that the cost of inaction is high",
          "position": 0,
          "objective": "What is the cost of not investing in innovative cancer treatments?",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "confidence": 0.6,
          "description": "Quantify what happens if the audience does nothing"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 5,
          "from": 3,
          "beatId": "78d6a8df-6efc-40db-93fc-ce9f8bc4283c",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Problem",
          "beatSlug": "sequoia-pitch-problem",
          "evidence": "Slides 3-5 present an overview of the current state of cancer treatment and the need for innovative solutions",
          "position": 0,
          "confidence": 0.8,
          "parentBeatName": "Complication",
          "parentBeatSlug": "complication"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 6,
      "slideType": "team_bio",
      "function": "other",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/6",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-6",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 6,
          "from": 6,
          "beatId": "cb201d80-14fd-45fd-a0cf-b75369822c0d",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Team",
          "beatSlug": "sequoia-pitch-team",
          "evidence": "Slide 6 presents the management team with deep expertise",
          "position": 3,
          "confidence": 0.8,
          "parentBeatName": "Evidence",
          "parentBeatSlug": "evidence"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 7,
      "slideType": "traction",
      "function": "show_traction",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/7",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-7",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 8,
      "slideType": "section_divider",
      "function": "transition",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/8",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-8",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 9,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a comparative framework to position the drug as a superior alternative to existing checkpoint inhibitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/9",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-9",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "5026d18e-139d-4879-9fd9-ca4f599102e8",
          "evidence": "The solution section presents Sotigalimab as a rationally designed and differentiated CD40 agonist",
          "position": 1,
          "objective": "Why is Sotigalimab a good solution?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "bfa88b56-3bff-4ff7-bf10-cf826d73f1e6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 9-11 present Sotigalimab as a solution, including its design and differentiation from other CD40 agonists",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 10,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a diagram of an antibody to map specific functional regions to their biological mechanisms.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/10",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-10",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "5026d18e-139d-4879-9fd9-ca4f599102e8",
          "evidence": "The solution section presents Sotigalimab as a rationally designed and differentiated CD40 agonist",
          "position": 1,
          "objective": "Why is Sotigalimab a good solution?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "bfa88b56-3bff-4ff7-bf10-cf826d73f1e6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 9-11 present Sotigalimab as a solution, including its design and differentiation from other CD40 agonists",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 11,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "Uses two 2x2 matrices to position competitors relative to Apexigen.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/11",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-11",
      "loopMatches": [
        {
          "to": 11,
          "from": 9,
          "name": "Golden Circle",
          "slug": "11-golden-circle",
          "bestFor": "Visionary leadership, brand positioning, mission statements",
          "matchId": "5026d18e-139d-4879-9fd9-ca4f599102e8",
          "evidence": "The solution section presents Sotigalimab as a rationally designed and differentiated CD40 agonist",
          "position": 1,
          "objective": "Why is Sotigalimab a good solution?",
          "structure": "The Why (Belief) -> The How (Process) -> The What (Result)",
          "confidence": 0.7,
          "description": "Invert the typical pitch by starting with why you exist, rather than what you do"
        }
      ],
      "arcBeatMatches": [
        {
          "to": 11,
          "from": 9,
          "beatId": "bfa88b56-3bff-4ff7-bf10-cf826d73f1e6",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Solution",
          "beatSlug": "sequoia-pitch-solution",
          "evidence": "Slides 9-11 present Sotigalimab as a solution, including its design and differentiation from other CD40 agonists",
          "position": 1,
          "confidence": 0.8,
          "parentBeatName": "Turn",
          "parentBeatSlug": "turn"
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 12,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a simple additive framework to show how immune response and clinical activity lead to a strategic positioning as a 'backbone' therapy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/12",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-12",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 13,
      "slideType": "traction",
      "function": "show_traction",
      "notes": null,
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/13",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-13",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 14,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The chart is a classic 'spider plot' used in oncology to track individual patient tumor burden over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/14",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-14",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 15,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Spider plot (swimmer plot variant) showing individual patient responses over time.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/15",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-15",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 16,
      "slideType": "testimonial",
      "function": "illustrate_case",
      "notes": "The slide uses a before-and-after medical imaging comparison to validate clinical efficacy.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/16",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-16",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de073-79f3-7749-b6d9-2feecaaa4d92",
      "docSlug": "3bbd721bd246637706dab09d5c4f3165",
      "documentTitle": "Apexigen | Investor Presentation Deck | 27 slides",
      "authorId": "apexigen",
      "authorName": "Apexigen",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2022-09-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 17,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes Kaplan-Meier survival curve and comparative efficacy tables.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de073-79f3-7749-b6d9-2feecaaa4d92/17",
      "deckHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92",
      "deckAnchorHref": "/decks/019de073-79f3-7749-b6d9-2feecaaa4d92#slide-17",
      "loopMatches": [],
      "arcBeatMatches": [
        {
          "to": 20,
          "from": 12,
          "beatId": "3b7829c3-3966-42d3-a835-880f62f71399",
          "arcName": "The Sequoia Pitch",
          "arcSlug": "sequoia-pitch",
          "beatName": "Traction",
          "beatSlug": null,
          "evidence": "Slides 12-20 present various traction metrics, including clinical trial results and partnerships",
          "position": 2,
          "confidence": 0.8,
          "parentBeatName": null,
          "parentBeatSlug": null
        }
      ],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}